Stoke Therapeutics, Inc. Expense Breakdown
No Expense Breakdown for STOK on this site yet.
- 2026-06-30: Zorevunersen -$28.24M; Payroll and Other Personnel Costs Research and Development -$18.22M; Payroll and Other Personnel Costs Sales, General and Administrative -$13.32M; Other Non Program Costs Sales, General and Administrative -$5.59M.
- 2025-06-30: Zorevunersen -$11.38M; Payroll and Other Personnel Costs Research and Development -$11.62M; Payroll and Other Personnel Costs Sales, General and Administrative -$8.98M; Other Non Program Costs Sales, General and Administrative -$3.32M.
Source checked: the stored Expense Breakdown page for STOK.
Expenses by product
Operating expenses: each quarter (3 month)
| Quarter end | Zorevunersen | Payroll and Other Personnel Costs Research and Development | Payroll and Other Personnel Costs Sales, General and Administrative | Other Non Program Costs Sales, General and Administrative | Other External Program Costs | Adoa | Others |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$28.24M | -$18.22M | -$13.32M | -$5.59M | -$3.99M | -$2.70M | Mecp2 $0.00 Syngap1 -$1.07M Other Non Program Costs Research and Development -$1.63M |
| 2025-06-30 | -$11.38M | -$11.62M | -$8.98M | -$3.32M | -$1.84M | -$1.75M | Mecp2 $200.00K Syngap1 -$818.00K Other Non Program Costs Research and Development -$1.61M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |